Kidney tissue regeneration using bioactive scaffolds incorporated with differentiating extracellular vesicles and intermediate mesoderm cells

Background To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal...

Full description

Saved in:
Bibliographic Details
Published inBiomaterials research Vol. 27; no. 1; pp. 1 - 2893
Main Authors Cha, Seung-Gyu, Rhim, Won-Kyu, Kim, Jun Yong, Lee, Eun Hye, Lee, Seung Yeon, Park, Jeong Min, Lee, Jeoung Eun, Yoon, Hyeji, Park, Chun Gwon, Kim, Bum Soo, Kwon, Tae Gyun, Lee, Youngmi, Lee, Dong Ryul, Han, Dong Keun
Format Journal Article
LanguageEnglish
Published London BioMed Central 05.12.2023
BioMed Central Ltd
한국생체재료학회
Subjects
Acids
Analysis
Angiogenesis
Basal cells
Biocompatibility
Biodegradability
Biomaterials
Cell culture
Cell differentiation
Cell growth
Chemistry and Materials Science
Chronic kidney failure
Extracellular matrix
Extracellular vesicles
Fibrosis
Kidney diseases
Lipoic acid
Magnesium
Materials Science
Mesoderm
Nephrectomy
Nitric oxide
Polylactide-co-glycolide
Progenitor cells
Regenerative medicine
Research Article
Ricinoleic acid
Stem cells
Tissue engineering
Zinc oxides
의공학
South Korea
United States > US
Intermediate mesoderm (IM)
Differentiating extracellular vesicle (dEV)
Kidney differentiation
PMEZ scaffold
Kidney tissue regeneration
Online AccessGet full text
ISSN2055-7124
1226-4601
2055-7124
DOI10.1186/s40824-023-00471-x

Cover

Abstract Background To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal basal cells, the incorporation of intermediate mesoderm (IM) cells and bioactive materials to control bioactivities of cells with supported scaffolds should be considered as a viable approach to enable the regeneration of the complex kidney structure via renal differentiation. Methods We developed PMEZ scaffolds by combining crucial bioactive components, such as ricinoleic acid-grafted Mg(OH) 2 (M), extracellular matrix (E), and alpha lipoic acid-conjugated ZnO (Z) integrated into biodegradable porous PLGA (P) platform. Additionally, we utilized differentiating extracellular vesicles (dEV) isolated during intermediate mesoderm differentiation into kidney progenitor cells, and IM cells were serially incorporated to facilitate kidney tissue regeneration through their differentiation into kidney progenitor cells in the 3/4 nephrectomy mouse model. Results The use of differentiating extracellular vesicles facilitated IM differentiation into kidney progenitor cells without additional differentiation factors. This led to improvements in various regeneration-related bioactivities including tubule and podocyte regeneration, anti-fibrosis, angiogenesis, and anti-inflammation. Finally, implanting PMEZ/dEV/IM scaffolds in mouse injury model resulted in the restoration of kidney function. Conclusions Our study has demonstrated that utilizing biodegradable PLGA-based scaffolds, which include multipotent cells capable of differentiating into various kidney progenitor cells along with supporting components, can facilitate kidney tissue regeneration in the mouse model that simulates CKD through 3/4 nephrectomy. Graphical Abstract
AbstractList BackgroundTo overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal basal cells, the incorporation of intermediate mesoderm (IM) cells and bioactive materials to control bioactivities of cells with supported scaffolds should be considered as a viable approach to enable the regeneration of the complex kidney structure via renal differentiation.MethodsWe developed PMEZ scaffolds by combining crucial bioactive components, such as ricinoleic acid-grafted Mg(OH)2 (M), extracellular matrix (E), and alpha lipoic acid-conjugated ZnO (Z) integrated into biodegradable porous PLGA (P) platform. Additionally, we utilized differentiating extracellular vesicles (dEV) isolated during intermediate mesoderm differentiation into kidney progenitor cells, and IM cells were serially incorporated to facilitate kidney tissue regeneration through their differentiation into kidney progenitor cells in the 3/4 nephrectomy mouse model.ResultsThe use of differentiating extracellular vesicles facilitated IM differentiation into kidney progenitor cells without additional differentiation factors. This led to improvements in various regeneration-related bioactivities including tubule and podocyte regeneration, anti-fibrosis, angiogenesis, and anti-inflammation. Finally, implanting PMEZ/dEV/IM scaffolds in mouse injury model resulted in the restoration of kidney function.ConclusionsOur study has demonstrated that utilizing biodegradable PLGA-based scaffolds, which include multipotent cells capable of differentiating into various kidney progenitor cells along with supporting components, can facilitate kidney tissue regeneration in the mouse model that simulates CKD through 3/4 nephrectomy.
Background To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal basal cells, the incorporation of intermediate mesoderm (IM) cells and bioactive materials to control bioactivities of cells with supported scaffolds should be considered as a viable approach to enable the regeneration of the complex kidney structure via renal differentiation. Methods We developed PMEZ scaffolds by combining crucial bioactive components, such as ricinoleic acid-grafted Mg(OH)2 (M), extracellular matrix (E), and alpha lipoic acid-conjugated ZnO (Z) integrated into biodegradable porous PLGA (P) platform. Additionally, we utilized differentiating extracellular vesicles (dEV) isolated during intermediate mesoderm differentiation into kidney progenitor cells, and IM cells were serially incorporated to facilitate kidney tissue regeneration through their differentiation into kidney progenitor cells in the 3/4 nephrectomy mouse model. Results The use of differentiating extracellular vesicles facilitated IM differentiation into kidney progenitor cells without additional differentiation factors. This led to improvements in various regeneration-related bioactivities including tubule and podocyte regeneration, anti-fibrosis, angiogenesis, and anti-inflammation. Finally, implanting PMEZ/dEV/IM scaffolds in mouse injury model resulted in the restoration of kidney function. Conclusions Our study has demonstrated that utilizing biodegradable PLGA-based scaffolds, which include multipotent cells capable of differentiating into various kidney progenitor cells along with supporting components, can facilitate kidney tissue regeneration in the mouse model that simulates CKD through 3/4 nephrectomy. KCI Citation Count: 4
Background To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal basal cells, the incorporation of intermediate mesoderm (IM) cells and bioactive materials to control bioactivities of cells with supported scaffolds should be considered as a viable approach to enable the regeneration of the complex kidney structure via renal differentiation. Methods We developed PMEZ scaffolds by combining crucial bioactive components, such as ricinoleic acid-grafted Mg(OH).sub.2 (M), extracellular matrix (E), and alpha lipoic acid-conjugated ZnO (Z) integrated into biodegradable porous PLGA (P) platform. Additionally, we utilized differentiating extracellular vesicles (dEV) isolated during intermediate mesoderm differentiation into kidney progenitor cells, and IM cells were serially incorporated to facilitate kidney tissue regeneration through their differentiation into kidney progenitor cells in the 3/4 nephrectomy mouse model. Results The use of differentiating extracellular vesicles facilitated IM differentiation into kidney progenitor cells without additional differentiation factors. This led to improvements in various regeneration-related bioactivities including tubule and podocyte regeneration, anti-fibrosis, angiogenesis, and anti-inflammation. Finally, implanting PMEZ/dEV/IM scaffolds in mouse injury model resulted in the restoration of kidney function. Conclusions Our study has demonstrated that utilizing biodegradable PLGA-based scaffolds, which include multipotent cells capable of differentiating into various kidney progenitor cells along with supporting components, can facilitate kidney tissue regeneration in the mouse model that simulates CKD through 3/4 nephrectomy. Graphical Keywords: Kidney tissue regeneration, PMEZ scaffold, Intermediate mesoderm (IM), Differentiating extracellular vesicle (dEV), Kidney differentiation
Background To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal basal cells, the incorporation of intermediate mesoderm (IM) cells and bioactive materials to control bioactivities of cells with supported scaffolds should be considered as a viable approach to enable the regeneration of the complex kidney structure via renal differentiation. Methods We developed PMEZ scaffolds by combining crucial bioactive components, such as ricinoleic acid-grafted Mg(OH) 2 (M), extracellular matrix (E), and alpha lipoic acid-conjugated ZnO (Z) integrated into biodegradable porous PLGA (P) platform. Additionally, we utilized differentiating extracellular vesicles (dEV) isolated during intermediate mesoderm differentiation into kidney progenitor cells, and IM cells were serially incorporated to facilitate kidney tissue regeneration through their differentiation into kidney progenitor cells in the 3/4 nephrectomy mouse model. Results The use of differentiating extracellular vesicles facilitated IM differentiation into kidney progenitor cells without additional differentiation factors. This led to improvements in various regeneration-related bioactivities including tubule and podocyte regeneration, anti-fibrosis, angiogenesis, and anti-inflammation. Finally, implanting PMEZ/dEV/IM scaffolds in mouse injury model resulted in the restoration of kidney function. Conclusions Our study has demonstrated that utilizing biodegradable PLGA-based scaffolds, which include multipotent cells capable of differentiating into various kidney progenitor cells along with supporting components, can facilitate kidney tissue regeneration in the mouse model that simulates CKD through 3/4 nephrectomy. Graphical Abstract
To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal basal cells, the incorporation of intermediate mesoderm (IM) cells and bioactive materials to control bioactivities of cells with supported scaffolds should be considered as a viable approach to enable the regeneration of the complex kidney structure via renal differentiation. We developed PMEZ scaffolds by combining crucial bioactive components, such as ricinoleic acid-grafted Mg(OH).sub.2 (M), extracellular matrix (E), and alpha lipoic acid-conjugated ZnO (Z) integrated into biodegradable porous PLGA (P) platform. Additionally, we utilized differentiating extracellular vesicles (dEV) isolated during intermediate mesoderm differentiation into kidney progenitor cells, and IM cells were serially incorporated to facilitate kidney tissue regeneration through their differentiation into kidney progenitor cells in the 3/4 nephrectomy mouse model. The use of differentiating extracellular vesicles facilitated IM differentiation into kidney progenitor cells without additional differentiation factors. This led to improvements in various regeneration-related bioactivities including tubule and podocyte regeneration, anti-fibrosis, angiogenesis, and anti-inflammation. Finally, implanting PMEZ/dEV/IM scaffolds in mouse injury model resulted in the restoration of kidney function. Our study has demonstrated that utilizing biodegradable PLGA-based scaffolds, which include multipotent cells capable of differentiating into various kidney progenitor cells along with supporting components, can facilitate kidney tissue regeneration in the mouse model that simulates CKD through 3/4 nephrectomy.
To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal basal cells, the incorporation of intermediate mesoderm (IM) cells and bioactive materials to control bioactivities of cells with supported scaffolds should be considered as a viable approach to enable the regeneration of the complex kidney structure via renal differentiation.BACKGROUNDTo overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have demonstrated the possibilities for complete kidney tissue regeneration. Given the challenges associated with the reproducibility of renal basal cells, the incorporation of intermediate mesoderm (IM) cells and bioactive materials to control bioactivities of cells with supported scaffolds should be considered as a viable approach to enable the regeneration of the complex kidney structure via renal differentiation.We developed PMEZ scaffolds by combining crucial bioactive components, such as ricinoleic acid-grafted Mg(OH)2 (M), extracellular matrix (E), and alpha lipoic acid-conjugated ZnO (Z) integrated into biodegradable porous PLGA (P) platform. Additionally, we utilized differentiating extracellular vesicles (dEV) isolated during intermediate mesoderm differentiation into kidney progenitor cells, and IM cells were serially incorporated to facilitate kidney tissue regeneration through their differentiation into kidney progenitor cells in the 3/4 nephrectomy mouse model.METHODSWe developed PMEZ scaffolds by combining crucial bioactive components, such as ricinoleic acid-grafted Mg(OH)2 (M), extracellular matrix (E), and alpha lipoic acid-conjugated ZnO (Z) integrated into biodegradable porous PLGA (P) platform. Additionally, we utilized differentiating extracellular vesicles (dEV) isolated during intermediate mesoderm differentiation into kidney progenitor cells, and IM cells were serially incorporated to facilitate kidney tissue regeneration through their differentiation into kidney progenitor cells in the 3/4 nephrectomy mouse model.The use of differentiating extracellular vesicles facilitated IM differentiation into kidney progenitor cells without additional differentiation factors. This led to improvements in various regeneration-related bioactivities including tubule and podocyte regeneration, anti-fibrosis, angiogenesis, and anti-inflammation. Finally, implanting PMEZ/dEV/IM scaffolds in mouse injury model resulted in the restoration of kidney function.RESULTSThe use of differentiating extracellular vesicles facilitated IM differentiation into kidney progenitor cells without additional differentiation factors. This led to improvements in various regeneration-related bioactivities including tubule and podocyte regeneration, anti-fibrosis, angiogenesis, and anti-inflammation. Finally, implanting PMEZ/dEV/IM scaffolds in mouse injury model resulted in the restoration of kidney function.Our study has demonstrated that utilizing biodegradable PLGA-based scaffolds, which include multipotent cells capable of differentiating into various kidney progenitor cells along with supporting components, can facilitate kidney tissue regeneration in the mouse model that simulates CKD through 3/4 nephrectomy.CONCLUSIONSOur study has demonstrated that utilizing biodegradable PLGA-based scaffolds, which include multipotent cells capable of differentiating into various kidney progenitor cells along with supporting components, can facilitate kidney tissue regeneration in the mouse model that simulates CKD through 3/4 nephrectomy.
Audience Academic
Author Lee, Jeoung Eun
Lee, Seung Yeon
Lee, Youngmi
Rhim, Won-Kyu
Cha, Seung-Gyu
Kwon, Tae Gyun
Yoon, Hyeji
Kim, Jun Yong
Park, Jeong Min
Kim, Bum Soo
Park, Chun Gwon
Han, Dong Keun
Lee, Dong Ryul
Lee, Eun Hye
Author_xml – sequence: 1
  givenname: Seung-Gyu
  surname: Cha
  fullname: Cha, Seung-Gyu
  organization: Department of Biomedical Science, CHA University
– sequence: 2
  givenname: Won-Kyu
  surname: Rhim
  fullname: Rhim, Won-Kyu
  organization: Department of Biomedical Science, CHA University
– sequence: 3
  givenname: Jun Yong
  surname: Kim
  fullname: Kim, Jun Yong
  organization: Department of Biomedical Science, CHA University, Department of Biomedical Engineering, SKKU Institute for Convergence, Sungkyunkwan University (SKKU), Intelligent Precision of Healthcare Convergence, SKKU Institute for Convergence, Sungkyunkwan University (SKKU)
– sequence: 4
  givenname: Eun Hye
  surname: Lee
  fullname: Lee, Eun Hye
  organization: Joint Institute for Regenerative Medicine, Kyungpook National University
– sequence: 5
  givenname: Seung Yeon
  surname: Lee
  fullname: Lee, Seung Yeon
  organization: Department of Biomedical Science, CHA University
– sequence: 6
  givenname: Jeong Min
  surname: Park
  fullname: Park, Jeong Min
  organization: Department of Biomedical Science, CHA University
– sequence: 7
  givenname: Jeoung Eun
  surname: Lee
  fullname: Lee, Jeoung Eun
  organization: Bundang Medical Center, CHA Advanced Research Institute, CHA University
– sequence: 8
  givenname: Hyeji
  surname: Yoon
  fullname: Yoon, Hyeji
  organization: Department of Chemistry and Nanoscience, Ewha Womans University
– sequence: 9
  givenname: Chun Gwon
  surname: Park
  fullname: Park, Chun Gwon
  organization: Department of Biomedical Engineering, SKKU Institute for Convergence, Sungkyunkwan University (SKKU), Intelligent Precision of Healthcare Convergence, SKKU Institute for Convergence, Sungkyunkwan University (SKKU)
– sequence: 10
  givenname: Bum Soo
  surname: Kim
  fullname: Kim, Bum Soo
  organization: Joint Institute for Regenerative Medicine, Kyungpook National University, Department of Urology, School of Medicine, Kyungpook National University
– sequence: 11
  givenname: Tae Gyun
  surname: Kwon
  fullname: Kwon, Tae Gyun
  organization: Joint Institute for Regenerative Medicine, Kyungpook National University, Department of Urology, School of Medicine, Kyungpook National University
– sequence: 12
  givenname: Youngmi
  surname: Lee
  fullname: Lee, Youngmi
  organization: Department of Chemistry and Nanoscience, Ewha Womans University
– sequence: 13
  givenname: Dong Ryul
  surname: Lee
  fullname: Lee, Dong Ryul
  organization: Department of Biomedical Science, CHA University, Bundang Medical Center, CHA Advanced Research Institute, CHA University
– sequence: 14
  givenname: Dong Keun
  orcidid: 0000-0003-4641-7883
  surname: Han
  fullname: Han, Dong Keun
  email: dkhan@cha.ac.kr
  organization: Department of Biomedical Science, CHA University
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003026047$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kstu1DAUhiNUREvpC7CyxIYipdhxLvYKjSouIyohlbK2PPZJ6jZjD3YyTB-Cd-ZkpipMhaosnMv3_XFO_pfZgQ8esuw1o2eMifp9KqkoypwWPKe0bFi-eZYdFbSq8oYV5cE_54fZSUo3lFJWMllW8kV2yAUtpWjkUfb7q7Me7sjgUhqBROjAQ9SDC56MyfmOLFzQZnBrIMnotg29TcR5E-IqIAeW_HLDNbGubSGCHxy6aMFmiNpA34-9jmQNyZkeEtHeojxAXIJFEsgSUrB4SSY2vcqet7pPcHK_Hmc_Pn28Ov-SX3z7PD-fXeSmEmLIrTasYbQxuqK8MKJkQlasMdYIZqVsQFYAVgvB-YJRTbkRGjSY2gho6trw4-zdLtfHVt0ap4J227UL6jaq2eXVXDHKa1HJAuEPO3g1LnDbBj8y6l6tolvqeLdV9594d41Ba0yoZd3IGhPe3ifE8HOENKilS9MHaw9hTKoQUnDGS8kRffMIvQlj9DgMVUhasIJzJB-oTvegnG_DNO0pVM2apsI6yLJE6uw_FB4Wls5gnVqH9_eE0z0BmQF_ZKfHlNT8--U-W-xYE0NKEdqHgTCqpoaqXUMVNlRtG6o2KIlHknHDtmy4M9c_rfKdmvA9voP4dzBPWH8AUPr9yw
CitedBy_id crossref_primary_10_3390_ijms251910386
crossref_primary_10_1186_s40580_024_00450_5
crossref_primary_10_1016_j_molliq_2024_126117
crossref_primary_10_1021_acsnano_4c07992
crossref_primary_10_3390_ijms25105242
Cites_doi 10.1038/nmat2904
10.1016/j.cej.2023.144174
10.1177/20417314211001545
10.1039/C9BM01103J
10.1186/s40824-022-00252-y
10.1021/acscentsci.8b00812
10.1002/smll.202105762
10.1038/nprot.2008.42
10.1016/j.mtla.2020.100785
10.1021/acs.analchem.6b02396
10.1039/D2BM01673G
10.1369/0022155419852932
10.1021/acsnano.1c01098
10.1177/0963689718797053
10.1177/20417314221084095
10.1038/ncb1596
10.1038/nrneph.2015.126
10.1016/j.bioactmat.2017.10.001
10.1177/20417314221122123
10.1089/scd.2008.0097
10.1002/smll.201906744
10.1177/20417314211059624
10.23876/j.krcp.19.051
10.1002/adhm.201500168
10.1016/j.bioactmat.2016.11.001
10.1016/S0140-6736(11)60178-5
10.1016/j.transproceed.2016.01.028
10.1016/j.nefroe.2017.03.004
10.3390/pharmaceutics14122661
10.1007/s00011-018-1131-1
10.1007/s13770-021-00426-0
10.1007/s13770-019-00184-0
10.1186/s13287-018-1105-9
10.1039/D0BM01656J
10.1038/s41598-019-49671-3
10.1634/stemcells.2006-0183
10.1007/s13770-022-00492-y
10.1038/ncb2904
10.1002/med.21736
10.1146/annurev-physiol-022516-034227
10.1038/s41557-020-00585-y
10.1186/s40824-022-00300-7
10.1186/s40824-022-00334-x
10.1016/j.semnephrol.2014.06.011
10.1186/s40824-016-0068-0
10.1016/j.semcdb.2021.09.017
10.1681/ASN.2013080831
10.1038/ncb2894
10.1177/2041731419884708
10.1016/j.mtbio.2023.100611
10.3390/ijms232315089
10.1038/s41581-022-00542-7
10.1002/stem.310
10.1007/s13770-019-00195-x
10.3402/jev.v4.27066
10.1038/s41598-018-34995-3
10.1016/j.addr.2021.113940
10.1046/j.1365-2672.2000.00791.x
10.1039/D0BM01934H
10.3389/fcell.2020.00183
10.1016/j.stem.2018.10.010
10.1186/s40580-022-00349-z
10.3390/cells11213366
10.1186/s40824-022-00289-z
10.1016/j.celrep.2016.03.076
10.1038/s41581-022-00586-9
10.1007/s13770-021-00365-w
10.1021/acsnano.8b02365
10.1242/dev.034876
10.1002/advs.202205336
10.1039/C7BM00479F
10.1186/s13287-018-0791-7
10.1111/nyas.13451
10.1007/s13770-021-00352-1
10.1002/bit.27173
ContentType Journal Article
Copyright The Author(s) 2023
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023. The Author(s).
Copyright_xml – notice: The Author(s) 2023
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023. The Author(s).
DBID C6C
AAYXX
CITATION
ISR
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
ACYCR
DOI 10.1186/s40824-023-00471-x
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
Gale In Context: Science
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Biological Science Database
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database





MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2055-7124
EndPage 2893
ExternalDocumentID oai_kci_go_kr_ARTI_10368592
PMC10696796
A775471944
10_1186_s40824_023_00471_x
GeographicLocations South Korea
United States--US
GeographicLocations_xml – name: South Korea
– name: United States--US
GrantInformation_xml – fundername: Ministry of Science and ICT, South Korea
  grantid: 2023R1A2C3003807; 2022R1I1A1A01068486; 23A0206L1
  funderid: http://dx.doi.org/10.13039/501100014188
GroupedDBID 0R~
5VS
7X7
8FE
8FH
8FI
8FJ
9ZL
AAFWJ
ABUWG
ACGFS
ACPRK
ADBBV
ADFRT
ADRAZ
ADUKV
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
ASPBG
AVWKF
BAPOH
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
EBLON
EBS
EMOBN
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
ISR
ITC
KQ8
LK8
M48
M7P
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQGLB
PQQKQ
PROAC
PUEGO
RBZ
RPM
RSV
SOJ
UKHRP
AAYXX
ALIPV
CITATION
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
ROL
7X8
5PM
4.4
ACYCR
AHSBF
EJD
H13
ID FETCH-LOGICAL-c588t-dac17107ca5032c84189517cdc81d997e95eeda8833b10a03c8aeaec6c8e766c3
IEDL.DBID 7X7
ISSN 2055-7124
1226-4601
IngestDate Wed Jul 23 03:12:19 EDT 2025
Thu Aug 21 18:36:01 EDT 2025
Fri Sep 05 00:11:25 EDT 2025
Fri Jul 25 10:23:41 EDT 2025
Tue Jun 17 22:19:24 EDT 2025
Tue Jun 10 21:15:43 EDT 2025
Fri Jun 27 06:07:03 EDT 2025
Tue Jul 01 01:12:30 EDT 2025
Thu Apr 24 23:11:25 EDT 2025
Sat Sep 06 07:28:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Intermediate mesoderm (IM)
Differentiating extracellular vesicle (dEV)
Kidney differentiation
PMEZ scaffold
Kidney tissue regeneration
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c588t-dac17107ca5032c84189517cdc81d997e95eeda8833b10a03c8aeaec6c8e766c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
https://biomaterialsres.biomedcentral.com/counter/pdf/10.1186/s40824-023-00471-x.pdf
ORCID 0000-0003-4641-7883
OpenAccessLink https://www.proquest.com/docview/2902123331?pq-origsite=%requestingapplication%
PMID 38049879
PQID 2902123331
PQPubID 2040249
PageCount 20
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10368592
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10696796
proquest_miscellaneous_2898313493
proquest_journals_2902123331
gale_infotracmisc_A775471944
gale_infotracacademiconefile_A775471944
gale_incontextgauss_ISR_A775471944
crossref_primary_10_1186_s40824_023_00471_x
crossref_citationtrail_10_1186_s40824_023_00471_x
springer_journals_10_1186_s40824_023_00471_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-12-05
PublicationDateYYYYMMDD 2023-12-05
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-05
  day: 05
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Biomaterials research
PublicationTitleAbbrev Biomater Res
PublicationYear 2023
Publisher BioMed Central
BioMed Central Ltd
한국생체재료학회
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: 한국생체재료학회
References e_1_3_7_62_2
e_1_3_7_60_2
e_1_3_7_20_2
e_1_3_7_43_2
e_1_3_7_66_2
e_1_3_7_22_2
e_1_3_7_41_2
e_1_3_7_64_2
e_1_3_7_24_2
e_1_3_7_47_2
e_1_3_7_26_2
e_1_3_7_45_2
e_1_3_7_68_2
e_1_3_7_28_2
e_1_3_7_49_2
Li H (e_1_3_7_73_2) 2021; 12
e_1_3_7_51_2
e_1_3_7_72_2
e_1_3_7_70_2
e_1_3_7_30_2
e_1_3_7_55_2
e_1_3_7_76_2
e_1_3_7_11_2
e_1_3_7_32_2
e_1_3_7_53_2
e_1_3_7_74_2
e_1_3_7_13_2
e_1_3_7_34_2
e_1_3_7_59_2
e_1_3_7_15_2
e_1_3_7_36_2
e_1_3_7_57_2
e_1_3_7_78_2
e_1_3_7_17_2
e_1_3_7_38_2
e_1_3_7_19_2
e_1_3_7_2_2
e_1_3_7_4_2
e_1_3_7_6_2
e_1_3_7_8_2
e_1_3_7_61_2
e_1_3_7_40_2
e_1_3_7_65_2
e_1_3_7_44_2
e_1_3_7_63_2
e_1_3_7_21_2
e_1_3_7_42_2
e_1_3_7_23_2
e_1_3_7_48_2
e_1_3_7_69_2
e_1_3_7_25_2
e_1_3_7_46_2
e_1_3_7_67_2
e_1_3_7_27_2
e_1_3_7_29_2
e_1_3_7_9_2
e_1_3_7_50_2
e_1_3_7_71_2
e_1_3_7_31_2
e_1_3_7_54_2
e_1_3_7_77_2
e_1_3_7_10_2
e_1_3_7_33_2
e_1_3_7_52_2
e_1_3_7_75_2
e_1_3_7_12_2
e_1_3_7_35_2
e_1_3_7_58_2
e_1_3_7_14_2
e_1_3_7_37_2
e_1_3_7_56_2
e_1_3_7_16_2
e_1_3_7_39_2
e_1_3_7_18_2
e_1_3_7_3_2
e_1_3_7_5_2
e_1_3_7_7_2
References_xml – ident: e_1_3_7_14_2
  doi: 10.1038/nmat2904
– ident: e_1_3_7_34_2
  doi: 10.1016/j.cej.2023.144174
– ident: e_1_3_7_48_2
  doi: 10.1177/20417314211001545
– ident: e_1_3_7_11_2
  doi: 10.1039/C9BM01103J
– ident: e_1_3_7_77_2
  doi: 10.1186/s40824-022-00252-y
– ident: e_1_3_7_25_2
  doi: 10.1021/acscentsci.8b00812
– ident: e_1_3_7_32_2
  doi: 10.1002/smll.202105762
– ident: e_1_3_7_62_2
  doi: 10.1038/nprot.2008.42
– ident: e_1_3_7_19_2
  doi: 10.1016/j.mtla.2020.100785
– ident: e_1_3_7_59_2
  doi: 10.1021/acs.analchem.6b02396
– ident: e_1_3_7_35_2
  doi: 10.1039/D2BM01673G
– ident: e_1_3_7_65_2
  doi: 10.1369/0022155419852932
– ident: e_1_3_7_40_2
– ident: e_1_3_7_50_2
  doi: 10.1021/acsnano.1c01098
– ident: e_1_3_7_58_2
  doi: 10.1177/0963689718797053
– ident: e_1_3_7_52_2
  doi: 10.1177/20417314221084095
– ident: e_1_3_7_42_2
  doi: 10.1038/ncb1596
– ident: e_1_3_7_74_2
  doi: 10.1038/nrneph.2015.126
– ident: e_1_3_7_22_2
  doi: 10.1016/j.bioactmat.2017.10.001
– ident: e_1_3_7_49_2
  doi: 10.1177/20417314221122123
– ident: e_1_3_7_37_2
  doi: 10.1089/scd.2008.0097
– ident: e_1_3_7_30_2
  doi: 10.1002/smll.201906744
– ident: e_1_3_7_47_2
  doi: 10.1177/20417314211059624
– ident: e_1_3_7_69_2
  doi: 10.23876/j.krcp.19.051
– ident: e_1_3_7_12_2
  doi: 10.1002/adhm.201500168
– ident: e_1_3_7_21_2
  doi: 10.1016/j.bioactmat.2016.11.001
– ident: e_1_3_7_2_2
  doi: 10.1016/S0140-6736(11)60178-5
– ident: e_1_3_7_36_2
  doi: 10.1016/j.transproceed.2016.01.028
– ident: e_1_3_7_68_2
  doi: 10.1016/j.nefroe.2017.03.004
– ident: e_1_3_7_29_2
  doi: 10.3390/pharmaceutics14122661
– ident: e_1_3_7_51_2
  doi: 10.1007/s00011-018-1131-1
– ident: e_1_3_7_23_2
  doi: 10.1007/s13770-021-00426-0
– ident: e_1_3_7_13_2
  doi: 10.1007/s13770-019-00184-0
– ident: e_1_3_7_55_2
  doi: 10.1186/s13287-018-1105-9
– ident: e_1_3_7_60_2
  doi: 10.1039/D0BM01656J
– ident: e_1_3_7_53_2
  doi: 10.1038/s41598-019-49671-3
– ident: e_1_3_7_3_2
  doi: 10.1634/stemcells.2006-0183
– ident: e_1_3_7_63_2
  doi: 10.1007/s13770-022-00492-y
– ident: e_1_3_7_10_2
  doi: 10.1038/ncb2904
– ident: e_1_3_7_33_2
  doi: 10.1002/med.21736
– ident: e_1_3_7_66_2
  doi: 10.1146/annurev-physiol-022516-034227
– ident: e_1_3_7_31_2
  doi: 10.1038/s41557-020-00585-y
– ident: e_1_3_7_45_2
  doi: 10.1186/s40824-022-00300-7
– ident: e_1_3_7_28_2
  doi: 10.1186/s40824-022-00334-x
– ident: e_1_3_7_64_2
  doi: 10.1016/j.semnephrol.2014.06.011
– volume: 12
  start-page: 1
  year: 2021
  ident: e_1_3_7_73_2
  article-title: Embryonic kidney development, stem cells and the origin of wilms Tumor
  publication-title: Genes (Basel)
– ident: e_1_3_7_72_2
  doi: 10.1186/s40824-016-0068-0
– ident: e_1_3_7_7_2
  doi: 10.1016/j.semcdb.2021.09.017
– ident: e_1_3_7_75_2
  doi: 10.1681/ASN.2013080831
– ident: e_1_3_7_9_2
  doi: 10.1038/ncb2894
– ident: e_1_3_7_16_2
  doi: 10.1177/2041731419884708
– ident: e_1_3_7_17_2
  doi: 10.1016/j.mtbio.2023.100611
– ident: e_1_3_7_39_2
  doi: 10.3390/ijms232315089
– ident: e_1_3_7_4_2
  doi: 10.1038/s41581-022-00542-7
– ident: e_1_3_7_67_2
  doi: 10.1002/stem.310
– ident: e_1_3_7_15_2
  doi: 10.1007/s13770-019-00195-x
– ident: e_1_3_7_43_2
  doi: 10.3402/jev.v4.27066
– ident: e_1_3_7_6_2
  doi: 10.1038/s41598-018-34995-3
– ident: e_1_3_7_56_2
  doi: 10.1016/j.addr.2021.113940
– ident: e_1_3_7_78_2
  doi: 10.1046/j.1365-2672.2000.00791.x
– ident: e_1_3_7_26_2
  doi: 10.1039/D0BM01934H
– ident: e_1_3_7_8_2
  doi: 10.3389/fcell.2020.00183
– ident: e_1_3_7_61_2
  doi: 10.1016/j.stem.2018.10.010
– ident: e_1_3_7_38_2
  doi: 10.1186/s40580-022-00349-z
– ident: e_1_3_7_71_2
  doi: 10.3390/cells11213366
– ident: e_1_3_7_27_2
  doi: 10.1186/s40824-022-00289-z
– ident: e_1_3_7_5_2
  doi: 10.1016/j.celrep.2016.03.076
– ident: e_1_3_7_70_2
  doi: 10.1038/s41581-022-00586-9
– ident: e_1_3_7_44_2
  doi: 10.1007/s13770-021-00365-w
– ident: e_1_3_7_24_2
  doi: 10.1021/acsnano.8b02365
– ident: e_1_3_7_76_2
  doi: 10.1242/dev.034876
– ident: e_1_3_7_18_2
  doi: 10.1002/advs.202205336
– ident: e_1_3_7_41_2
  doi: 10.1039/C7BM00479F
– ident: e_1_3_7_46_2
  doi: 10.1186/s13287-018-0791-7
– ident: e_1_3_7_54_2
  doi: 10.1111/nyas.13451
– ident: e_1_3_7_57_2
  doi: 10.1007/s13770-021-00352-1
– ident: e_1_3_7_20_2
  doi: 10.1002/bit.27173
SSID ssj0001419459
Score 2.2672117
Snippet Background To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies...
To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies have...
Background To overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies...
BackgroundTo overcome the limitations of current alternative therapies for chronic kidney disease (CKD), tissue engineering-mediated regeneration strategies...
SourceID nrf
pubmedcentral
proquest
gale
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Acids
Analysis
Angiogenesis
Basal cells
Biocompatibility
Biodegradability
Biomaterials
Cell culture
Cell differentiation
Cell growth
Chemistry and Materials Science
Chronic kidney failure
Extracellular matrix
Extracellular vesicles
Fibrosis
Kidney diseases
Lipoic acid
Magnesium
Materials Science
Mesoderm
Nephrectomy
Nitric oxide
Polylactide-co-glycolide
Progenitor cells
Regenerative medicine
Research Article
Ricinoleic acid
Stem cells
Tissue engineering
Zinc oxides
의공학
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKucAB8RSBgsxD4gCGzdpJ7ANCFaJqQeUArNSb5djOsuo2gTiL2h_Bf2bGmyykKj3twRMnOw_PjD3-hpDnLsOo3EomSyWYqLzEQ8IJK7KyMLyECLrCRPHwc74_Ex-PsqMtMrQ76hkYLkztsJ_UrF2-Pv159g4M_m00eJm_Cdg0WTDwPgzBD1MGMeVV8Ew5JmOHfbgf91wEpOyxf1oKUQcTkIwM92gunGbkq_oV-0rdVqNo9Hwt5bkD1ein9m6SG32ASXfXGnGLbPn6Nrn-D-zgHfL708LV_ox2kem09fOIPY0iolgHP6flojFxIaTBmqpqli5QhHFYox57R3H7lg7NVToULzwF63xr8CQAS1vpLx9iyR01taOIStHGWyqdpyc-YAe2E4q04S6Z7X349n6f9W0ZmM2k7JgzNoW4pMBmChzELFIJYVphnYXYV6nCqwwcr8EuxmU6MRNupfHG29xKX-S55ffIdt3U_j6hlRXSu5S7QmWCO6CTTkkLy87UCO95QtJBANr2mOXYOmOpY-4ic70Wmgah6Sg0fZqQl5tnfqwROy6lfopy1cjDGmtt5mYVgj74-kXvIjhgARojEvKiJ6oaZKTpry7An0D0rBHlzogSbNWOhp-B-uhju9AI642_80YftxqSlwP4SuwGoKYwyaBeejAIPVUIxs85TxPyZDOM82OVXO2bFdBIJTniTQLj5EgtN5zA145H6sX3iCqeTnKFm4oJeTVo8N-3_5-BDy7_2Ifk2hQtCguAsh2y3bUr_wjCuK58HG3zD4F9RMg
  priority: 102
  providerName: Scholars Portal
– databaseName: SpringerOpen Free (Free internet resource, activated by CARLI)
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagXOCAeIrQgsxD4gAR67Wd2MeqompBcAAq9WY5trOs2jooyVbwI_jPzHiTbVMBEqccPHaSmfF4xh5_Q8hLL9ErdypXlRa5qIPCQ8JZXsqqtLwCD7rGQPHjp-LgSLw_lscDTA7ehbl8fs9U8bbDgsgih5UlR2BDloO_eEMyXqSD2WLvYj9FQDgu9Xgv5o9dJ2vPYIGvx7aeeJdXcyOvHJCmdWf_Drk9OIx0dy3hu-RaiPfIrUswgvfJrw9LH8NP2icm0jYsEpY0spxiXvuCVsvGJsNGO2frujn1HUVYhjWKcfAUt2PpWCylR3FBL7DbrcWdfUxVpeehSyl01EZPEWWiTbdO-kDPQocV1c4o0nYPyNH-u697B_lQZiF3Uqk-99Yx8DNKLI7AQWyCKXC7Sucd-LJal0FLWEgtViWu2MzOuFM22OAKp0JZFI4_JFuxieERobUTKnjGfaml4B7olNfKgRmZWxECzwgbBWDcgEGOpTBOTYpFVGHWQjMgNJOEZn5k5PWmz_c1Asc_qZ-jXA3yMGLuzMKuus4cfvlsdhHsrwQtERl5NRDVDTLSDlcR4CcQDWtCuTOhhLnnJs0vQH3MiVsahOnG56IxJ62BYOQQvhLR_fUcBhnVywwWojNzjeD6nHOWkWebZhwfs95iaFZAo7TiiB8JjFMTtdxwAl87bYnLbwklHGJ9jZuEGXkzavDF2__OwMf_R75Nbs5xhmGCj9whW327Ck_ATeurp2l-_gbeqzju
  priority: 102
  providerName: Springer Nature
Title Kidney tissue regeneration using bioactive scaffolds incorporated with differentiating extracellular vesicles and intermediate mesoderm cells
URI https://link.springer.com/article/10.1186/s40824-023-00471-x
https://www.proquest.com/docview/2902123331
https://www.proquest.com/docview/2898313493
https://pubmed.ncbi.nlm.nih.gov/PMC10696796
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003026047
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 생체재료학회지, 2023, 27(0), , pp.2874-2893
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfY9gIPaHyJwqjMh8QDWGtqJ3Ge0Kg2baBNaDCpb5ZjO6XalmxJisYfwf_Mneu0ZBJ7aVX58tG78_nufP4dIe9sjF65kUzmmWCicBI3CUcsjfNU8xw86AIDxeOT5PBMfJnG05Bwa0JZZWcTvaG2lcEc-e44QzByznn06eqaYdco3F0NLTQ2yJaHLgN9TqfpOsciIET3_dIi8DKYgOCjOzcjk90Gey0LBosWQ8zEiN301qZgoTfKuuh5n7drJ29toPp16WCbPAwOJd1basAjcs-Vj8mDf2AGn5A_X-e2dL9p65lMazfzWNMoEop17zOazyvtDR9tjC6K6sI2FGEblijHzlJM19KumUqL4oSrwK7XGjP_WMpKf7nGl9hRXVqKKBS1P5XSOnrpGuy4dkmRtnlKzg72f0wOWWjDwEwsZcusNhH4ISk2T-AgVhFJcMtSYw34ulmWuiyGhVZj1-I8GukRN1I77UxipEuTxPBnZLOsSvec0MII6WzEbQrC4hbopM2kATMz1sI5PiBRJwBlAkY5tsq4UD5WkYlaCk2B0JQXmroZkA-ra66WCB13Ur9BuSrkYYm1NTO9aBp19P1U7SEYYAoaIwbkfSAqKmSkDkcV4E8gWlaPcqdHCXPT9IbfgvqoczNXCOON37NKndcKgpUjeEtE_8_GcJNOvVSwII1a6_uAvF4N4_2xKq501QJoZCY54ksC42RPLVecwMf2R8r5T48iHo2SDJOIA_Kx0-D10__PwBd3v-xLcn-MMwoLfuIdstnWC_cK3LY2H_q5OSRbn_dPvp3Cr0kyGfoUCHweC_kX7AdFkA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELba7QE4IH5FoID5EwewukmcxDkgVKDVLtuuUGml3oxjO8uqbVKSLLQPwavwjMxkk11Sid562oMnTtYznhnb4-8j5KUJMCvXgokk5oynVuAhYZ9FQRIpP4EMOsWF4u44HBzwz4fB4Qr5096FwbLK1ifWjtrkGvfIN7wYwch933ffn_5gyBqFp6sthcbcLEb2_Bcs2cp3w0-g31eet721_3HAGlYBpgMhKmaUdiGsRsgF4MNXcldAlhFpoyF1i-PIxgHEDYUkvInbV31fC2WV1aEWNgpD7UO_q2SN443WHln7sDX-srfc1eFuzGuGNhfyGsZhudPe1BHhRonszpxBmGSI0uiys040bGLCalaknXz3YrXmhSPbOhJu3yI3mxSWbs5t7jZZsdkdcuMfYMO75PdoajJ7TqtarbSwkxrdGo2AYqX9hCbTXNWulpZapWl-bEqKQBFzXGVrKG4Q05a-pUIDgqcgkhQKzxqweJb-tGVd1EdVZijiXhT1PZjK0hNbIsfbCUXZ8h45uBIV3Se9LM_sA0JTzYU1rm-iOOC-ATlhYqHBsXmKW-s7xG0VIHWDio7kHMeyXh2JUM6VJkFpslaaPHPIm8Uzp3NMkEuln6NeJY5hhtU8EzUrSzn8uic3EX4wAovhDnndCKU5DqRqLkfAn0B8ro7kekcSvIHuNL8A85FHeioROBx_J7k8KiQsj4bwlcg3EHvQSWtesvFZpVzOMIc8WzRj_1iHl9l8BjIiFj4iWsLAiY5ZLkYCX9ttyabfa9xytx_GuG3pkLetBS_f_v8BfHj5xz4l1wb7uztyZzgePSLXPZxdWG4UrJNeVczsY0gaq-RJM1Mp-XbVzuEvZtuAOQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9QwDI9gSAgeEJ9aYUD4kHiAatdL2iaP0-C0YzAhYNLeojRJj9O2dGp7CP4I_mfstL2tEyDxdA9x2qvt2E5i_0zIS5tiVG5ELArJY146gZeEkzhPi1yzAiLoEjeKHw-yvUP-_ig9ulDFH7LdhyvJrqYBUZp8u31my26Ji2y7wTbJPAZ_EyPcYRJDFHmNo-vD69ps9_yUhcMmPZVDtcwfp448Um-Xr_q6HMWclzMmL12bBm80u01u9WEk3enkfodccf4uuXkBXPAe-bW_tN79pG1gLa3dIiBMoyAoZrsvaLGsdDB3tDG6LKsT21AEa-iwjZ2leEhLhxYqLQoRZoE1rzWe92MCK_3umpBYR7W3FLEn6lCL0jp66hrss3ZKkba5Tw5n777u7sV984XYpEK0sdUmgegjx5YJDITJEwHBWG6sgQhXytzJFNyrxl7FRTLRE2aEdtqZzAiXZ5lhD8iGr7zbJLQ0XDibMJvLlDMLdMJKYcC4TDV3jkUkGQSgTI9Mjg0yTlTYoYhMdUJTIDQVhKZ-ROT1es5Zh8vxT-rnKFeFPPSYUbPQq6ZR8y-f1Q5CAOagJTwir3qiskJG6r5AAT4CMbJGlFsjSliRZjT8AtRHHZulQvBu_F1U6rhWsEWZw79EzH85hYcM6qV6u9GoqUTIfcZYEpFn62F8PubCeVetgEZIwRBVEhgnRmq55gS-djzil98CdngyySQeHUbkzaDB52__OwMf_h_5U3L909uZ-jA_2H9EbkxxsWEGULpFNtp65R5DHNcWT8JS_Q1z-EQi
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kidney+tissue+regeneration+using+bioactive+scaffolds+incorporated+with+differentiating+extracellular+vesicles+and+intermediate+mesoderm+cells&rft.jtitle=Biomaterials+research&rft.au=Cha%2C+Seung-Gyu&rft.au=Won-Kyu+Rhim&rft.au=Jun+Yong+Kim&rft.au=Lee%2C+Eun+Hye&rft.date=2023-12-05&rft.pub=BioMed+Central&rft.issn=1226-4601&rft.eissn=2055-7124&rft.volume=27&rft.spage=1&rft_id=info:doi/10.1186%2Fs40824-023-00471-x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2055-7124&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2055-7124&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2055-7124&client=summon